Sea Lane Ventures Team
Photo of Marianne Bulger, Investor at Sea Lane Ventures
Marianne Bulger
Sweet spot: $15.0M
Range: $10.0M - $30.0M
Investors in Canada, Investors in Toronto (Ontario)
Investors in Human Capital/HRTech (Seed), Investors in Sales & CRM (Seed), Investors in Developer Tools (Series A), Investors in Developer Tools (Seed), Investors in Human Capital/HRTech (Series A), Investors in Data Services (Seed), Investors in Data Services (Series A), Investors in Sales & CRM (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in Data Services (Seed), Investors in Developer Tools (Seed), Investors in Developer Tools (Seed), Investors in Data Services (Seed), Investors in Human Capital/HRTech (Seed), Investors in Human Capital/HRTech (Seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in Data Services (Series A), Investors in Data Services (Series A), Investors in Developer Tools (Series A), Investors in Developer Tools (Series A), Investors in Human Capital/HRTech (Series A), Investors in Human Capital/HRTech (Series A), Investors in Sales & CRM (Series A), Investors in Sales & CRM (Series A), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Future of Work (Series A), Investors in Future of Work (Seed), Investors in Gig Economy (Seed), Investors in Gig Economy (Seed), Investors in Gig Economy (Series A), Investors in Gig Economy (Series A), Investors in Gig Economy (Series A), Investors in Gig Economy (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed)
Photo of Ling Wong, General Partner at Sea Lane Ventures
Ling Wong
Sea Lane Ventures·General Partner
Sweet spot: $10.0M
Range: $500K - $50.0M
Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series B), Investors in Investors who were founders (Other Lists), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in AI (Series A)